High prevalence of target diseases, product launches, increasing strategic developments such as partnerships and agreements, increasing demand of painless or minimally invasive treatment, and increased resistance to existing therapies are key factors contributing to the increasing adoption of the Hedgehog pathway restraint during the forecast period. According to the current...